Amgen (AMGN) – Downgrades
-
Leerink Partners Downgrades Amgen (AMGN) to Market Perform, 'Awaiting Obesity Results'
-
Amgen & Eli Lilly upgraded to Overweight at Wells Fargo, Merck downgraded to Equal Weight
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to AMGN Stock Lookup